Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis

骨膜炎 肺纤维化 基质细胞蛋白 特发性肺纤维化 纤维化 医学 癌症研究 转化生长因子 心脏纤维化 肌成纤维细胞 博莱霉素 肺 转化生长因子β 免疫学 病理 生物 细胞外基质 内科学 细胞生物学 化疗
作者
Yasuhiro Nanri,Satoshi Nunomura,Yasuhiro Terasaki,Tomohito Yoshihara,Yusuke Hirano,Yasuyuki Yokosaki,Yukie Yamaguchi,Carol A. Feghali‐Bostwick,Keiichi Ajito,Shoichi Murakami,Simon James Conway,Kenji Izuhara
出处
期刊:American Journal of Respiratory Cell and Molecular Biology [American Thoracic Society]
卷期号:62 (2): 204-216 被引量:73
标识
DOI:10.1165/rcmb.2019-0245oc
摘要

Abstract Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized as progressive and irreversible fibrosis in the interstitium of lung tissues. There is still an unmet need to develop a novel therapeutic drug for IPF. We have previously demonstrated that periostin, a matricellular protein, plays an important role in the pathogenesis of pulmonary fibrosis. However, the underlying mechanism of how periostin causes pulmonary fibrosis remains unclear. In this study, we sought to learn whether the cross-talk between TGF-β (transforming growth factor-β), a central mediator in pulmonary fibrosis, and periostin in lung fibroblasts leads to generation of pulmonary fibrosis and whether inhibitors for integrin αVβ3, a periostin receptor, can block pulmonary fibrosis in model mice and the TGF-β signals in fibroblasts from patients with IPF. We found that cross-talk exists between TGF-β and periostin signals via αVβ3/β5 converging into Smad3. This cross-talk is necessary for the expression of TGF-β downstream effector molecules important for pulmonary fibrosis. Moreover, we identified several potent integrin low-molecular-weight inhibitors capable of blocking cross-talk with TGF-β signaling. One of the compounds, CP4715, attenuated bleomycin-induced pulmonary fibrosis in vivo in mice and the TGF-β signals in vitro in fibroblasts from patients with IPF. These results suggest that the cross-talk between TGF-β and periostin can be targeted for pulmonary fibrosis and that CP4715 can be a potential therapeutic agent to block this cross-talk.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai的应助被大白采纳,获得10
刚刚
一叶瓷发布了新的文献求助10
2秒前
孟滴滴完成签到,获得积分10
2秒前
123完成签到,获得积分10
2秒前
焓舒发布了新的文献求助10
2秒前
laglms发布了新的文献求助10
3秒前
dsjy发布了新的文献求助10
3秒前
cc完成签到,获得积分10
4秒前
英姑的应助被Songzhu采纳,获得10
4秒前
My_magnum_opus的应助被zhikaiyici采纳,获得30
4秒前
852的应助被XS_QI采纳,获得10
5秒前
晨曦发布了新的文献求助10
6秒前
123完成签到 ,获得积分10
7秒前
CodeCraft的应助被孟滴滴采纳,获得10
8秒前
NexusExplorer的应助被hyc采纳,获得10
9秒前
CodeCraft的应助被东京蔡徐坤采纳,获得10
9秒前
TR完成签到,获得积分10
9秒前
11秒前
科研通AI6.3的应助被刘甜甜采纳,获得30
11秒前
李爱国的应助被12345678采纳,获得10
11秒前
科研通AI6.3的应助被XZM采纳,获得10
12秒前
CipherSage的应助被renn采纳,获得10
12秒前
13秒前
orixero的应助被坦率的凉面采纳,获得10
13秒前
14秒前
心灵美雁易完成签到,获得积分10
14秒前
16秒前
JamesPei的应助被眼睛大大有采纳,获得10
16秒前
搜集达人的应助被Cynthia采纳,获得10
16秒前
不吃香菜发布了新的文献求助10
17秒前
东京蔡徐坤完成签到,获得积分20
18秒前
oumeili发布了新的文献求助10
18秒前
zzz发布了新的文献求助10
19秒前
okkk发布了新的文献求助10
19秒前
李宗洋完成签到,获得积分10
19秒前
20秒前
20秒前
21秒前
liuyimu完成签到,获得积分10
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184061
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829878
捐赠科研通 7781058
什么是DOI,文献DOI怎么找? 3434216
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674